Secondary Logo

Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Review Articles

Patient Responses to Ipilimumab, a Novel Immunopotentiator for Metastatic Melanoma

How Different are these From Conventional Treatment Responses?

Pennock, Gregory K., MD*; Waterfield, William, MD; Wolchok, Jedd D., MD, PhD

Author Information
American Journal of Clinical Oncology: December 2012 - Volume 35 - Issue 6 - p 606-611
doi: 10.1097/COC.0b013e318209cda9
  • Buy

Abstract

© 2012 by Lippincott Williams & Wilkins, Inc